August 8, 2014 / 5:51 AM / 3 years ago

Nicox to co-promote eye drug with Bausch + Lomb in the US

1 Min Read

PARIS, Aug 8 (Reuters) - French pharmaceutical firm Nicox said it had notified Bausch + Lomb, a division of Valeant Pharmaceuticals, that it would exercise its option to co-promote eye drug latanoprostene bunod in the United States.

Nicox and B+L will now start negotiating a co-promotion agreement which will be signed at a later stage, Nicox said in a statement on Friday. (Reporting by Natalie Huet; Editing by Stephen Coates)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below